Real-world effectiveness and safety of tralokinumab therapy in moderate-to-severe atopic dermatitis: insights from the TREATgermany registry

Clinical and Experimental Dermatology 2026

View at publisher
Authors: Jan N. Hartmann, Inken Harder, Dora Stölzl, Melina Fonfara, Luise Heinrich, Barbara Kind, Jochen Schmitt, Thomas Werfel, Stephan Weidinger
DOI: 10.1093/ced/llaf516
Cited by: 0
References: 5

Abstract

Real-world evidence from the TREATgermany registry demonstrated that tralokinumab has robust effectiveness and good tolerability and may provide improvements also in difficult-to-treat body areas.

Fields of Study & Subjects

Dermatology and Skin Diseases Contact Dermatitis and Allergies Asthma and respiratory diseases

Publication details

Journal / source
Clinical and Experimental Dermatology
Volume
51
Issue
3
Pages
494–497
Publication date
8 January 2026
Language
EN